Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary

Saved in:
Bibliographic Details
Published in:The FASEB journal 2007-11, Vol.21 (13), p.3417-3418
Main Author: Bylund, David B
Format: Article
Language:English
Subjects:
Animals
Antidepressive Agents - adverse effects
Antidepressive Agents - pharmacology
Antidepressive Agents - therapeutic use
Depression - drug therapy
Disease Models, Animal
Humans
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c273t-310d30758c32cc504b848cc7540d75345038f138a6039ed6e858bd58641bb5f03
container_end_page 3418
container_issue 13
container_start_page 3417
container_title The FASEB journal
container_volume 21
creator Bylund, David B
description
doi_str_mv 10.1096/fj.07-1102ufm-A
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1096_fj_07_1102ufm_A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17967928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c273t-310d30758c32cc504b848cc7540d75345038f138a6039ed6e858bd58641bb5f03</originalsourceid><addsrcrecordid>eNpFkEtrwzAQhEVpadK0595a_QEnK8uS5d5C6QsCPaQ5FiHr4TjElpHsQv59XRwoe9iBnW8ZBqF7AksCBV-5wxLyhBBIB9ck6ws0J4xCwgWHSzQHUaQJ51TM0E2MBwAgQPg1mpG84HmRijn63tqj1X3dVjhO6qfuaxuxag3u9xa3dgi-26vQKO2Pvjph78ZjXxvbBRvjKLEJQ4XVyPr2Ca-x9k1j216F0y26cuoY7d15L9Du9eXr-T3ZfL59PK83iU5z2ieUgKGQM6FpqjWDrBSZ0DpnGZic0YwBFY5QoTjQwhpuBROlYYJnpCyZA7pAq-mvDj7GYJ3sQt2MASQB-VeUdAcJuTwXJdcj8TAR3VA21vz7z82MhsfJ4JSXqgp1lLttCoQCiJSScX4B49lvGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bylund, David B</creator><creatorcontrib>Bylund, David B</creatorcontrib><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.07-1102ufm-A</identifier><identifier>PMID: 17967928</identifier><language>eng</language><publisher>United States: The Federation of American Societies for Experimental Biology</publisher><subject>Animals ; Antidepressive Agents - adverse effects ; Antidepressive Agents - pharmacology ; Antidepressive Agents - therapeutic use ; Depression - drug therapy ; Disease Models, Animal ; Humans</subject><ispartof>The FASEB journal, 2007-11, Vol.21 (13), p.3417-3418</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c273t-310d30758c32cc504b848cc7540d75345038f138a6039ed6e858bd58641bb5f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17967928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bylund, David B</creatorcontrib><title>Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><subject>Animals</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Depression - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpFkEtrwzAQhEVpadK0595a_QEnK8uS5d5C6QsCPaQ5FiHr4TjElpHsQv59XRwoe9iBnW8ZBqF7AksCBV-5wxLyhBBIB9ck6ws0J4xCwgWHSzQHUaQJ51TM0E2MBwAgQPg1mpG84HmRijn63tqj1X3dVjhO6qfuaxuxag3u9xa3dgi-26vQKO2Pvjph78ZjXxvbBRvjKLEJQ4XVyPr2Ca-x9k1j216F0y26cuoY7d15L9Du9eXr-T3ZfL59PK83iU5z2ieUgKGQM6FpqjWDrBSZ0DpnGZic0YwBFY5QoTjQwhpuBROlYYJnpCyZA7pAq-mvDj7GYJ3sQt2MASQB-VeUdAcJuTwXJdcj8TAR3VA21vz7z82MhsfJ4JSXqgp1lLttCoQCiJSScX4B49lvGg</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Bylund, David B</creator><general>The Federation of American Societies for Experimental Biology</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20071101</creationdate><title>Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary</title><author>Bylund, David B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c273t-310d30758c32cc504b848cc7540d75345038f138a6039ed6e858bd58641bb5f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Depression - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bylund, David B</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bylund, David B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>21</volume><issue>13</issue><spage>3417</spage><epage>3418</epage><pages>3417-3418</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><cop>United States</cop><pub>The Federation of American Societies for Experimental Biology</pub><pmid>17967928</pmid><doi>10.1096/fj.07-1102ufm-A</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2007-11, Vol.21 (13), p.3417-3418
issn 0892-6638
1530-6860
language eng
recordid cdi_crossref_primary_10_1096_fj_07_1102ufm_A
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Antidepressive Agents - adverse effects
Antidepressive Agents - pharmacology
Antidepressive Agents - therapeutic use
Depression - drug therapy
Disease Models, Animal
Humans
title Selecting selectivities and the neuropharmacology of antidepressant drug action: A commentary
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-10T01%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selecting%20selectivities%20and%20the%20neuropharmacology%20of%20antidepressant%20drug%20action:%20A%20commentary&rft.jtitle=The%20FASEB%20journal&rft.au=Bylund,%20David%20B&rft.date=2007-11-01&rft.volume=21&rft.issue=13&rft.spage=3417&rft.epage=3418&rft.pages=3417-3418&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.07-1102ufm-A&rft_dat=%3Cpubmed_cross%3E17967928%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c273t-310d30758c32cc504b848cc7540d75345038f138a6039ed6e858bd58641bb5f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/17967928&rfr_iscdi=true